Abses Paru

01Pathophysiology

A lung abscess is a circumscribed collection of pus within necrotic lung parenchyma, resulting from microbial infection that destroys tissue and forms a walled-off cavity. Understanding the mechanism begins with the most common precipitant: aspiration of oropharyngeal flora.

In patients with impaired consciousness or a suppressed gag/cough reflex (due to alcohol intoxication, seizures, sedation, or neuromuscular disease), oropharyngeal secretions laden with bacteria silently enter the lower airways. The aspirated material settles in gravity-dependent lung segments. When the patient aspirates while supine, the posterior segment of the right upper lobe and the superior segment of the right lower lobe are the classic locations. The right lung is disproportionately affected because the right main bronchus is wider, shorter, and more vertically oriented than the left, creating a preferential path for aspirated material.

Once bacteria colonize the lung parenchyma, a necrotizing pneumonitis develops. Anaerobic organisms thrive in this low-oxygen, devitalized tissue. Over the course of one to two weeks, the center of the infected area undergoes liquefactive necrosis. Eventually, the necrotic center communicates with a bronchus, allowing the liquefied material to drain partially into the airway. This is the moment the patient develops the hallmark putrid sputum and when the chest radiograph begins to show the characteristic air-fluid level within the cavity. The foul odor is a direct consequence of anaerobic bacterial metabolism producing volatile sulfur compounds and short-chain fatty acids.

The constitutional symptoms (fever, night sweats, weight loss) reflect the chronicity and intensity of the infection. Unlike typical bacterial pneumonia that presents acutely over hours to days, an anaerobic lung abscess evolves over weeks, mimicking a subacute to chronic process. This indolent timeline is itself a diagnostic clue on exam vignettes.

In secondary lung abscess, the mechanism differs. Bronchial obstruction by a tumor creates post-obstructive pneumonia that then cavitates. Septic emboli from right-sided endocarditis (common in IV drug users) seed multiple peripheral lung areas, producing bilateral, multiple cavitary lesions. Necrotizing organisms like Staphylococcus aureus or Klebsiella pneumoniae can directly destroy lung tissue even without aspiration, producing cavities through their virulence factors (toxins, proteases).

02Classification and Clinical Manifestation

Clinical Manifestation by Phase

03Diagnostic Workup

The chest X-ray is the appropriate first step whenever a lung abscess is clinically suspected. The classic finding is a round or oval thick-walled cavity containing an air-fluid level, situated in a gravity-dependent lung segment. On a PA film, look for the air-fluid level as a horizontal line within the cavity. A lateral view is helpful to confirm the posterior location, which is characteristic of aspiration.

However, plain radiography has limitations. It cannot reliably distinguish a lung abscess from an empyema with a bronchopleural fistula (which also shows an air-fluid level), nor can it rule out an underlying endobronchial lesion. This is why CT chest with IV contrast is the confirmatory and most accurate test. On CT, a lung abscess appears as a round, thick-walled cavity that forms acute angles with the chest wall, situated within the lung parenchyma. In contrast, an empyema is a lenticular (lens-shaped) collection that forms obtuse angles with the chest wall, compresses adjacent lung, and shows the "split pleura sign" (enhancing visceral and parietal pleura separated by fluid). This distinction is a frequently tested concept.

CT also evaluates for obstructing endobronchial lesions. If the cavity is located in a non-dependent segment, or if the patient lacks classic aspiration risk factors, an underlying malignancy must be considered. Squamous cell carcinoma of the lung is the most common lung cancer to cavitate.

Sputum cultures are ordered but have practical limitations. Expectorated sputum is contaminated by oral anaerobes and is unreliable for anaerobic culture. If an anaerobic etiology is strongly suspected clinically (putrid sputum, aspiration risk), empiric treatment is often initiated without definitive microbiologic confirmation. For cases where microbiologic data is essential (failure of empiric therapy, immunocompromised host), transthoracic needle aspiration or bronchoscopic sampling with protected specimen brush can provide uncontaminated specimens.

Bronchoscopy is not routine but becomes important in two scenarios. First, when an obstructing lesion is suspected (patient older than 50, no aspiration risk, non-dependent location). Second, when the abscess fails to improve after adequate antibiotic therapy, to obtain directed cultures and exclude malignancy.

04Management and Treatment

Acute stabilization begins with airway and hemodynamic assessment. Position the patient with the affected lung in a dependent position (affected side down) to prevent spillage of abscess contents into the contralateral lung, though this maneuver is more relevant to procedural scenarios.

Empiric antibiotic therapy is the cornerstone of treatment. For a community-acquired, aspiration-related primary lung abscess, clindamycin has been the traditional first-line choice due to its excellent anaerobic coverage, good lung tissue penetration, and activity against microaerophilic streptococci. However, ampicillin-sulbactam is increasingly favored in clinical practice because it provides equivalent anaerobic and streptococcal coverage with a lower risk of Clostridioides difficile infection.

A critical point: metronidazole should never be used as monotherapy for lung abscess. Although metronidazole covers strict anaerobes, it lacks activity against microaerophilic and facultative streptococci (Peptostreptococcus, Streptococcus milleri group), which are frequent co-pathogens in aspiration pneumonia. If metronidazole is used, it must be combined with penicillin or another agent covering these organisms.

IV-to-oral transition occurs when the patient is afebrile, clinically improving, and tolerating oral intake. The total duration extends for a minimum of 4 to 8 weeks. The endpoint is radiographic improvement: repeat chest X-ray should show decreasing cavity size. Treatment is continued until the cavity has resolved or only a small, stable residual abnormality remains. Premature discontinuation leads to relapse.

Failure to improve after 7 to 10 days of appropriate antibiotics should prompt reassessment. Consider broadening antibiotic coverage, obtaining CT-guided percutaneous drainage (especially for abscesses greater than 6 cm), and performing bronchoscopy to exclude obstruction.

Surgical intervention (typically lobectomy or segmentectomy) is reserved for abscesses refractory to 6 to 8 weeks of medical therapy, cavities complicated by uncontrolled hemorrhage, bronchopleural fistula, or when an underlying malignancy is confirmed.

Contraindications and Cautions

Clindamycin carries a well-known risk of C. difficile-associated diarrhea. In patients with a prior history of C. difficile infection, ampicillin-sulbactam is the preferred alternative. Percutaneous drainage must be performed cautiously in patients on anticoagulation or with coagulopathy due to hemorrhage risk.

05Differential Diagnosis and Distractors

06Traps and High-Yield Pearls

The most common way students lose points on lung abscess questions is by confusing it with empyema when both show an air-fluid level on the chest radiograph. The exam will test whether you can apply the CT-based distinctions: round cavity with acute chest wall angles (abscess) versus lenticular collection with obtuse angles and the split pleura sign (empyema). If a vignette presents a patient with a persistent air-fluid level that fails to improve with antibiotics, the next best step shifts from medical management to image-guided drainage or bronchoscopy, not immediate surgery.

Another frequent trap involves the location of the cavity. When the vignette describes a cavitary lesion in a non-dependent segment (for example, the anterior segment of the upper lobe) in a patient without aspiration risk factors, the question is steering you toward an obstructing malignancy as the underlying cause, and the next best step is bronchoscopy, not simply starting antibiotics. Always match the segment location with the clinical scenario.

A third pitfall is selecting metronidazole monotherapy. Students often reason that anaerobes are the primary pathogen and therefore metronidazole alone should suffice. This is incorrect. Metronidazole lacks coverage against the microaerophilic streptococci that are almost always co-present in aspiration-related abscesses. It must be paired with penicillin if chosen at all.

Finally, students frequently underestimate the treatment duration. A two-week antibiotic course, which suffices for community-acquired pneumonia, is inadequate for a lung abscess. The standard is 4 to 8 weeks with radiographic follow-up confirming resolution. Premature cessation is a setup for relapse and is a tested concept.

The core competency being assessed in lung abscess questions is your ability to integrate the clinical context (aspiration risk, chronicity, putrid sputum), interpret imaging correctly (distinguishing abscess from empyema and from malignancy), choose the right antibiotic regimen (and avoid metronidazole monotherapy), and recognize when the workup must pivot toward bronchoscopy to exclude an underlying obstructing lesion.